Bristol-Myers Squibb Company
GLUCOKINASE ACTIVATORS AND METHODS OF USING SAME
Last updated:
Abstract:
A compound, enantiomer, prodrug, diastereomer, or salt is provided which is an activator of the enzyme glucokinase and thus is believed to be useful in as treating diabetes and related diseases, which compound has the structure (I). A method for treating diabetes and related disease employing the compound, enantiomer, prodrug, diastereomer, or salt is also provided. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
21 Jul 2017
Issue date:
1 Aug 2019